Dr. Nadolsky responds to the common line that people should just eat less and move more instead of taking Ozempic.
Recap by typeshit. Post by @drnadolsky on Instagram.
A short Facebook share with no context on who used the peptides, where it happened or what followed.
Benzinga notes a 1.89% after-hours gain for Lilly stock, with Novo Nordisk also tagged. No further detail on what drove the move.
Mikhail Varshavski tells Fox News why protein matters, especially for GLP-1 users. He has a paid partnership with Quest Nutrition.
2:07:50
A live Q&A session covering GLP-1 drugs including Zepbound, Wegovy and Foundayo, with the host taking questions from viewers.
CNA Lifestyle asked doctors how the oral and injectable forms of Wegovy differ and what risks people should weigh before trying either.
Gen Z use beats every other generation, and appearance was its top reason. Korean regulators are also weighing tighter controls on Wegovy and Mounjaro.
Loading…